Dr. Vivek's AI Dr. Vivek's AI
Support us
🔗 You are viewing a shared knowledge page for: Hip Replacement
← New Search

Hip Replacement

Educational clinical summary of Hip Replacement for doctors and students: definition, workup, management, and key caveats. Not a substitute for guidelines.

Maintained by Dr. Vivek Karn Review process: editorial policy

Disclaimer: This information is intended for educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made by a qualified healthcare professional based on the individual patient's condition, circumstances, and available evidence. Always consult with a healthcare provider for any health concerns or before making any decisions related to your health or treatment.

Overview

  • Definition: Hip replacement, also known as total hip arthroplasty (THA), is a surgical procedure in which the diseased or damaged components of the hip joint (the acetabulum and femoral head) are removed and replaced with artificial prosthetic components (implants). The goal is to alleviate pain, improve joint function, and enhance quality of life.
  • Epidemiology: THA is one of the most successful and frequently performed orthopedic procedures worldwide.
    • Incidence: Over 450,000 THAs are performed annually in the United States, with numbers steadily increasing due to an aging population and expanded indications.
    • Demographics:
      • Age: While traditionally performed in older adults (60-80 years), there is a growing trend of THA in younger, more active patients. The average age is typically in the mid-to-late 60s.
      • Gender: Slightly more common in females, often reflecting higher rates of osteoarthritis and osteoporosis-related conditions.
      • Indications: Primary osteoarthritis accounts for approximately 90% of THAs. Other indications include rheumatoid arthritis, avascular necrosis, post-traumatic arthritis, hip fractures (often hemiarthroplasty or THA in certain cases), and developmental dysplasia of the hip.
  • Classification:
    • Total Hip Arthroplasty (THA): Replacement of both the femoral head and the acetabulum. This is the most common type of hip replacement.
    • Hemiarthroplasty: Replacement of only the femoral head, with the patient's native acetabulum remaining intact. Primarily used for displaced femoral neck fractures in elderly, low-demand patients.
      • Unipolar Hemiarthroplasty: A single component articulating with the native acetabulum.
      • Bipolar Hemiarthroplasty: A femoral head with two articulating surfaces (a small head within a larger shell) to potentially reduce acetabular wear.
    • Revision Hip Arthroplasty: Replacement of one or more components of a previously implanted hip prosthesis due to failure (e.g., aseptic loosening, infection, dislocation).
    • Surgical Approaches:
      • Posterior Approach: Most common; involves detaching posterior soft tissues (external rotators, capsule). Good exposure but higher dislocation risk initially.
      • Anterior Approach (Direct Anterior Approach - DAA): Muscle-sparing, often touted for faster recovery and lower dislocation risk. Requires specialized instruments and experience.
      • Lateral/Anterolateral Approach: Involves detachment or splitting of the abductor muscles. Intermediate dislocation risk.
    • Fixation Methods:
      • Cemented Fixation: Uses bone cement (polymethyl methacrylate, PMMA) to secure components to bone. Common in elderly patients with poorer bone quality.
      • Uncemented (Press-Fit) Fixation: Components have a porous or roughened surface to allow bone ingrowth for biological fixation. Common in younger, active patients with good bone quality.
      • Hybrid Fixation: Combines cemented femoral stem with an uncemented acetabular cup, or vice versa.

Pathophysiology

  • Mechanism: The need for hip replacement typically arises from degenerative joint disease, where the articular cartilage covering the femoral head and acetabulum erodes, leading to bone-on-bone friction, inflammation, and structural damage.
    • Osteoarthritis (OA): The most common cause. Characterized by progressive breakdown of articular cartilage, subchondral bone sclerosis, osteophyte formation, and joint space narrowing. This leads to pain, stiffness, and loss of motion.
    • Rheumatoid Arthritis (RA): An autoimmune inflammatory condition causing synovitis, cartilage destruction, and bone erosion in multiple joints, including the hip.
    • Avascular Necrosis (AVN): Interruption of blood supply to the femoral head, leading to bone death and collapse, causing rapid destruction of the articular surface.
    • Post-traumatic Arthritis: Damage to the joint cartilage and bone following a hip fracture or dislocation, leading to premature degeneration.
    • Developmental Dysplasia of the Hip (DDH): Abnormal development of the hip joint, leading to instability, incongruity, and early onset OA.
    • Other: Ankylosing spondylitis, Paget's disease, certain tumors, and failed previous hip surgeries.
  • Risk Factors:
    • Age: Increased risk of OA with advancing age.
    • Obesity: Increases mechanical load on the hip joint, accelerating cartilage wear. Body Mass Index (BMI) >30 kg/m² is a significant risk factor for OA progression.
    • Genetics: Family history of OA increases individual risk.
    • Previous Hip Injury/Trauma: Fractures, dislocations, or other injuries can lead to post-traumatic arthritis.
    • Developmental Abnormalities: DDH, Legg-Calve-Perthes disease, slipped capital femoral epiphysis (SCFE).
    • Inflammatory Arthritis: Conditions like RA, ankylosing spondylitis.
    • Systemic Conditions leading to AVN: Long-term corticosteroid use, excessive alcohol consumption, sickle cell disease, Gaucher's disease, deep-sea diving (caisson disease).
    • High-Impact Activities: Repetitive stress on the joint, though less significant than other factors.
  • Protective Factors:
    • Maintaining a Healthy Weight: Reduces load on the hip joint, slowing cartilage degeneration.
    • Regular, Low-Impact Exercise: Strengthens muscles around the hip and maintains joint mobility without excessive stress (e.g., swimming, cycling).
    • Injury Prevention: Avoiding falls and high-impact trauma.
    • Management of Underlying Conditions: Effective treatment of inflammatory arthritis or systemic diseases to minimize joint damage.

Clinical Presentation

Signs and Symptoms

  • Cardinal Features:
    • Groin Pain: Most common and characteristic symptom, often radiating to the buttock, outer thigh, or knee. Typically described as a deep ache.
    • Weight-Bearing Pain: Pain exacerbated by standing, walking, or prolonged activity.
    • Stiffness: Especially noticeable after periods of rest (e.g., morning stiffness, stiffness after sitting). Limits range of motion.
    • Functional Limitation: Difficulty with activities of daily living (ADLs) such as walking, climbing stairs, getting in and out of a car, putting on shoes/socks, and sexual activity.
    • Limp (Trendelenburg Gait): Due to pain, weakness of hip abductors, or leg length discrepancy.
  • Early Signs:
    • Intermittent mild groin pain, often noticed after activity.
    • Mild stiffness, especially in the morning, which improves with movement.
    • Difficulty with internal rotation of the hip.
  • Advanced Signs:
    • Constant, severe pain, even at rest or at night.
    • Significant loss of hip range of motion, particularly internal rotation, flexion, and abduction.
    • Significant gait disturbance (severe limp, use of walking aids).
    • Leg length discrepancy (often limb shortening on the affected side).
    • Muscle atrophy around the hip and thigh.
    • Impact on sleep and psychological well-being due to chronic pain and disability.
  • Atypical Presentations:
    • Isolated knee pain (referred pain from the hip).
    • Predominant buttock or trochanteric pain (though usually combined with groin pain).
    • Mechanical symptoms like clicking or catching, though less common with advanced OA.

Physical Examination

  • Inspection:
    • Gait Analysis: Observe for antalgic gait (limping to avoid pain), Trendelenburg gait (pelvic drop on the unaffected side during single-limb stance, indicating abductor weakness).
    • Posture: Look for lumbar lordosis compensation.
    • Muscle Atrophy: Quadriceps and gluteal atrophy on the affected side.
    • Leg Length Discrepancy (LLD): Measure from anterior superior iliac spine (ASIS) to medial malleolus. Significant LLD (>1-2 cm) can contribute to symptoms.
  • Palpation:
    • Tenderness over the groin (hip joint), greater trochanter (bursitis), or sacroiliac joint (referred pain).
    • Assess for hip effusion (difficult to palpate deeply).
  • Special Tests:
    • Range of Motion (ROM): Systematically assess active and passive ROM in all planes.
      • Flexion: Normal 120-130 degrees. Reduced.
      • Extension: Normal 10-20 degrees. Reduced.
      • Abduction: Normal 40-50 degrees. Significantly reduced and painful.
      • Adduction: Normal 20-30 degrees. Reduced.
      • Internal Rotation: Normal 30-40 degrees. Often the first and most severely limited motion in hip OA.
      • External Rotation: Normal 40-50 degrees.
      • Pain at the extremes of motion is characteristic.
    • Strength Testing: Assess hip flexors, extensors, abductors, and adductors. Abductor weakness is common.
    • Pain Provocation: Pain on rotation of the hip, especially internal rotation in flexion.
    • Neurovascular Assessment: Crucial, especially pre-operatively, to rule out nerve impingement or vascular compromise.

Diagnostic Approach

History Taking

  • Key Questions:
    • Pain Characteristics: Location (groin, buttock, thigh, knee), quality (ache, sharp), severity (0-10 scale), onset, duration, aggravating factors (activity, weight-bearing, night), alleviating factors (rest, medication).
    • Functional Limitations: Specific difficulties with ADLs (walking distance, stairs, standing, sitting, getting dressed, sleep disturbance). Use validated questionnaires like the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) or Harris Hip Score (HHS) for objective assessment.
    • Impact on Quality of Life: Effects on work, hobbies, social activities, psychological well-being.
    • Previous Treatments: Non-surgical interventions (physical therapy, pain medications, injections, assistive devices) and their efficacy.
    • Medical Comorbidities: Cardiovascular disease, diabetes, obesity, pulmonary conditions, renal/hepatic disease, neurological conditions, bleeding disorders, history of infections – crucial for surgical risk assessment.
    • Medications: Current medications, allergies.
    • Social History: Smoking, alcohol use, home environment (stairs, support system).
    • Patient Expectations: Understanding what the patient hopes to achieve with surgery.
  • Red Flags: Warning signs requiring urgent attention, though less common for elective THA:
    • Acute onset of severe pain with inability to bear weight, especially after trauma (suggests fracture).
    • Fever, chills, severe malaise, and warmth/redness over the joint (suggests septic arthritis or periprosthetic joint infection in a previous replacement).
    • Progressive neurological deficits (e.g., foot drop) (rare, but could indicate nerve compression).
    • Sudden, severe pain and instability in a previously replaced hip (suggests dislocation).

Laboratory Tests

  • First-Line (Pre-operative Screening):
    • Complete Blood Count (CBC): Assess for anemia, infection (elevated WBC). Hemoglobin <12 g/dL may require optimization.
    • Basic Metabolic Panel (BMP) / Comprehensive Metabolic Panel (CMP): Renal and hepatic function, electrolytes.
    • Coagulation Studies (PT/INR, PTT): Assess bleeding risk, especially if on anticoagulants.
    • Urinalysis (UA): Rule out asymptomatic bacteriuria, which should be treated before surgery to reduce infection risk.
    • Blood Type and Screen: For potential transfusion needs.
    • Electrocardiogram (ECG): For patients over 50 or with cardiac history.
    • Chest X-ray: For patients over 50 or with pulmonary history.
  • Confirmatory (Specific Indications):
    • Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP): Elevated in inflammatory arthritis or infection. Used if infection is suspected pre-operatively (e.g., revision surgery).
    • Serum Albumin/Prealbumin: Assess nutritional status, which impacts healing.
    • HbA1c: For diabetic patients, target <7.0% (ideally <6.5%) pre-operatively to minimize infection risk.
    • Urine Drug Screen: May be required by some institutions.
  • Monitoring:
    • Post-operatively: Serial CBC (monitor for blood loss), BMP (monitor electrolytes, renal function).
    • Long-term: ESR/CRP if periprosthetic joint infection is suspected.

Imaging

  • Recommended (Standard):
    • Anteroposterior (AP) Pelvis Radiograph: Weight-bearing view often preferred to assess joint space narrowing.
    • Lateral Hip Radiograph (e.g., Frog-leg lateral or True lateral): Provides a perpendicular view of the femoral head and neck.
    • Findings in Hip OA:
      • Joint space narrowing: Asymmetrical loss of cartilage.
      • Osteophytes: Bone spurs at the joint margins.
      • Subchondral sclerosis: Increased density of bone beneath the cartilage.
      • Subchondral cysts: Fluid-filled sacs in the bone.
      • Bone deformity: Changes in femoral head or acetabular shape.
  • Advanced (Specialized Imaging when needed):
    • Magnetic Resonance Imaging (MRI):
      • Excellent for evaluating soft tissues, cartilage, and bone marrow.
      • Indications: Suspected avascular necrosis (early stages where X-rays are normal), stress fractures, labral tears (though not a primary indication for THA itself, helps rule out other causes of pain), occult fractures.
      • Less useful for advanced OA where X-rays are diagnostic.
    • Computed Tomography (CT) Scan:
      • Excellent for detailed bone anatomy, complex fractures, and pre-operative planning for revision surgery or cases with severe deformity (e.g., DDH).
      • Used for templating and assessing bone stock.
      • Can be used to assess acetabular coverage and femoral version.
    • Bone Scintigraphy (Bone Scan):
      • Indications: Differentiate between aseptic loosening and infection in a painful THA (though often combined with other tests), identify stress fractures, or metastatic disease.
    • Arthrography (CT or MR Arthrography):
      • Injection of contrast into the joint. Used to evaluate capsular integrity, labral tears, or loose bodies, but rarely indicated for THA planning.

Management

Acute Management (Pre-operative)

  • Immediate (Pre-operative Optimization): The period leading up to elective surgery is critical for optimizing patient health and reducing risks.
    • Medical Clearance: Comprehensive pre-operative medical evaluation by a primary care physician or internist to assess and optimize comorbidities (cardiac, pulmonary, renal, diabetic control).
    • Medication Review: Adjustment or temporary cessation of medications, especially anticoagulants/antiplatelets (e.g., warfarin, clopidogrel, DOACs - bridging strategies vary), NSAIDs (discontinue 5-7 days prior), and certain supplements.
    • Anemia Management: Treat anemia if present (e.g., iron supplementation, erythropoietin) to reduce need for perioperative transfusions. Target Hgb >12 g/dL.
    • Infection Screening and Eradication: Treat any active infections (e.g., UTIs, dental infections, skin infections) before surgery. Nasal swabs for Staphylococcus aureus colonization with decolonization (e.g., mupirocin) if positive.
    • Nutritional Optimization: Address malnutrition if present.
  • Stabilization:
    • Patient Education: Thorough counseling on the surgical procedure, expected recovery, potential risks, pain management strategies, and post-operative precautions (e.g., dislocation precautions based on approach).
    • Physical Therapy Pre-habilitation: Exercises to strengthen muscles and improve flexibility may improve post-operative outcomes.
    • Smoking Cessation: Advise patients to stop smoking at least 4-6 weeks prior to surgery to reduce pulmonary complications, wound healing issues, and infection risk.
    • Weight Management: Encourage weight loss in obese patients to reduce surgical complications (infection, dislocation, DVT) and improve implant longevity.
  • Emergency: Not applicable for elective THA. However, in cases of emergent hip fracture requiring THA or hemiarthroplasty, the focus is on rapid stabilization, pain control, and surgical fixation within 24-48 hours.

Chronic Management (Surgical Intervention and Post-operative Care)

  • Pharmacological:
    • Pre-operative Prophylactic Antibiotics: Administered typically within 60 minutes prior to incision (e.g., Cefazolin 2g IV, Cefazolin 3g IV if BMI ≥ 120 kg). Repeat dose intra-operatively for long procedures (>3-4 hours) or significant blood loss. Continued for a maximum of 24 hours post-operatively for primary THA.
    • Pain Management (Multimodal):
      • Opioids: Oral oxycodone, hydrocodone, IV morphine, hydromorphone (acute post-op). Taper as pain subsides.
      • NSAIDs/COX-2 Inhibitors: (e.g., celecoxib, ibuprofen) If no contraindications (renal impairment, GI bleed risk), initiated post-op for anti-inflammatory and analgesic effects.
      • Acetaminophen: Regular dosing (e.g., 1000 mg every 6 hours) is a cornerstone of multimodal analgesia.
      • Gabapentin/Pregabalin: May be used for neuropathic pain component, or pre-emptively to reduce opioid requirements.
      • Regional Anesthesia: Spinal, epidural, or peripheral nerve blocks (e.g., fascia iliaca block, PENG block) for perioperative pain control.
    • Venous Thromboembolism (VTE) Prophylaxis:
      • Initiated typically 12-24 hours post-operatively.
      • Pharmacological: Low molecular weight heparin (LMWH, e.g., enoxaparin 30 mg SC BID or 40 mg SC QD), oral factor Xa inhibitors (e.g., rivaroxaban 10 mg QD, apixaban 2.5 mg BID), or warfarin (INR target 2.0-3.0). Duration typically 10-14 days for THA, some guidelines recommend up to 35 days.
      • Mechanical: Intermittent pneumatic compression (IPC) devices, elastic stockings (TED hose). Used for all patients, especially those with contraindications to pharmacological agents.
    • Laxatives/Stool Softeners: (e.g., docusate, senna) To counteract opioid-induced constipation.
  • Non-pharmacological:
    • Physical Therapy: Crucial for recovery. Begins day 0 or 1 post-op. Focus on early mobilization, gait training, strengthening exercises (quadriceps, glutes), ROM exercises, and transfer training.
    • Occupational Therapy: Addresses ADLs, home modifications, and safe use of adaptive equipment (e.g., raised toilet seat, shower bench).
    • Patient Education: Reinforce hip precautions (if applicable to surgical approach), wound care, signs of infection, and importance of adherence to rehabilitation program.
    • Weight-Bearing: Typically full weight-bearing as tolerated for uncemented components, immediate full weight-bearing for cemented components unless otherwise specified by surgeon.
  • Monitoring:
    • Early Post-op: Vital signs, neurovascular checks of the extremity, wound drainage, pain levels, mental status.
    • Hospital Stay: Monitoring for DVT/PE, infection, dislocation, surgical site hematoma.
    • Long-term:
      • Clinical Follow-up: Regular check-ups (e.g., 6 weeks, 3 months, 6 months, 1 year, then periodically - e.g., every 2-5 years) to assess pain, function, gait, and identify complications.
      • Radiographic Follow-up: AP pelvis and lateral hip X-rays at initial follow-up, then periodically (e.g., 1 year, then every 5 years) to monitor for implant loosening, wear, osteolysis, or component subsidence. More frequent if symptoms arise.
      • Wear Debris: Specific concern for polyethylene wear, potentially leading to osteolysis.

Treatment Algorithms

  • First-Line (Indications for Primary THA):
    1. Severe Hip Pain: Refractory to non-surgical management, significantly impacting daily activities and quality of life.
    2. Radiographic Evidence of Advanced Arthritis: Joint space narrowing, osteophytes, subchondral sclerosis/cysts.
    3. Functional Impairment: Documented limitations in gait, ROM, and ADLs.
    4. Failure of Non-operative Management: At least 3-6 months of conservative treatment including activity modification, physical therapy, weight management, analgesics (NSAIDs, acetaminophen), and often corticosteroid injections.
    5. Patient Motivation and Realistic Expectations: Understanding of the procedure and commitment to rehabilitation.
    6. Medical Fitness for Surgery: Acceptable risk profile after comprehensive medical clearance.
  • Second-Line (Alternative Treatments / Revision Indications):
    • Revision THA: Indicated for failed primary THA due to complications such as:
      • Aseptic loosening (most common long-term reason for failure)
      • Periprosthetic joint infection (PJI)
      • Recurrent dislocation
      • Periprosthetic fracture
      • Component wear/osteolysis
      • Implant breakage
      • Leg length discrepancy causing significant symptoms.
    • Hip Arthrodesis (Fusion): Rarely performed now, usually for young, active patients with severe post-traumatic arthritis and inability to undergo THA, or as a salvage procedure for failed THA with severe infection. Leads to permanent stiffness.
    • Girdlestone Resection Arthroplasty: Excision of the femoral head and neck without prosthetic replacement. Salvage procedure for severe, uncontrollable infection or multiple failed THAs, resulting in a flail pseudoarthrosis (very poor function, significant limb shortening).
  • Refractory Cases:
    • For persistent pain or complications after THA, a thorough investigation is paramount:
      • Infection Workup: ESR, CRP, joint aspiration (for cell count, differential, culture, alpha-defensin).
      • Radiographs: To assess for loosening, wear, fracture.
      • CT/MRI: For specific concerns (e.g., bone stock loss, occult fracture, soft tissue pathology).
      • Advanced Imaging: Bone scan, PET scan, or labeled leukocyte scan if infection is highly suspected but initial workup is inconclusive.
    • Management depends on the cause:
      • Aseptic loosening: Revision THA.
      • Infection: Often requires two-stage revision (implant removal, debridement, antibiotic spacer, followed by reimplantation after infection eradication), or one-stage revision in highly selected cases.
      • Recurrent dislocation: Consider surgical approach modification, larger femoral head, constrained liner, or revision.
      • Periprosthetic fracture: Varies from non-operative management to open reduction internal fixation (ORIF) or revision THA depending on fracture pattern and implant stability.

Complications

  • Common (Early and Late):
    • Pain: Post-operative pain is expected, but persistent or new pain warrants investigation.
    • Swelling and Bruising: Normal in the immediate post-operative period.
    • Minor Wound Complications: Superficial infection, delayed wound healing, hematoma.
    • Leg Length Discrepancy (LLD): Perceived or actual LLD can occur, typically within 1-2 cm. Greater discrepancies may require shoe lift or revision.
    • Nerve Palsy: Sciatic nerve (most common, presenting as foot drop) or femoral nerve injury. Incidence 0.1-2%, often transient, sometimes due to stretch or direct trauma.
    • Thigh Pain: Especially with uncemented stems, can be transient or chronic.
    • Heterotopic Ossification (HO): Formation of bone in soft tissues around the joint. Can lead to stiffness. Prophylaxis with NSAIDs (e.g., indomethacin 25 mg TID for 3-6 weeks) or single dose radiation in high-risk patients.
  • Serious (Life-threatening or Major Morbidity):
    • Periprosthetic Joint Infection (PJI): Devastating complication. Incidence 0.5-2%. Can be acute (within 3 months), delayed (3-24 months), or late (>24 months). Requires extensive treatment, often two-stage revision.
    • Venous Thromboembolism (VTE):
      • Deep Vein Thrombosis (DVT): Incidence without prophylaxis 40-60%; with prophylaxis 1-5%. Symptoms: calf pain, swelling, tenderness.
      • Pulmonary Embolism (PE): Incidence without prophylaxis 1-10%; with prophylaxis <1%. Symptoms: sudden shortness of breath, chest pain, tachycardia. PE is a leading cause of death after THA.
    • Dislocation: Occurs when the femoral head comes out of the acetabular cup. Incidence 1-5% for primary THA, higher for revision. Risk factors: posterior approach (historically), small femoral head, component malposition, soft tissue laxity, patient non-compliance with precautions. Most occur within first 3 months.
    • Periprosthetic Fracture: Fracture of the femur or pelvis around the implant. Incidence 0.1-5%, higher in revision surgery. Can occur intra-operatively or post-operatively (trauma, stress fracture).
    • Neurovascular Injury: Injury to major arteries or nerves (e.g., femoral artery/vein, sciatic nerve). Rare but serious.
    • Anesthetic Complications: Adverse reactions to anesthesia, cardiac events (MI, arrhythmia), stroke, respiratory failure.
  • Long-term:
    • Aseptic Loosening: The most common long-term reason for revision. Occurs due to bone resorption or failure of fixation at the bone-implant interface, often from wear particle-induced osteolysis.
    • Polyethylene Wear: Gradual erosion of the plastic liner, creating particles that trigger an inflammatory response leading to osteolysis and aseptic loosening.
    • Osteolysis: Bone destruction due to inflammatory reaction to wear particles, leading to implant loosening.
    • Implant Fractures: Rare, but components can fatigue and fracture over time.
    • Implant Instability/Dislocation: Can recur many years post-op.

Prognosis

  • Factors:
    • Pre-operative Condition: Severity of arthritis, patient's age, BMI, overall health, and functional status significantly influence outcomes. Younger, healthier patients generally have better long-term functional results.
    • Surgical Technique: Meticulous surgical technique, proper component positioning, and appropriate implant selection are critical.
    • Implant Longevity: Materials (e.g., highly cross-linked polyethylene, ceramic-on-ceramic bearings) and fixation methods (cemented vs. uncemented) affect implant survival.
    • Patient Compliance: Adherence to post-operative precautions and rehabilitation exercises is crucial for optimal recovery and preventing complications like dislocation.
    • Comorbidities: Uncontrolled diabetes, obesity, smoking, and cardiovascular disease increase complication rates and may negatively impact recovery.
  • Survival:
    • Implant Survival: Modern THA prostheses have excellent long-term survival rates.
      • 90-95% at 10 years.
      • 80-90% at 15 years.
      • 70-80% at 20 years.
      • Survival rates are generally lower in younger, more active patients who place higher demands on their implants.
    • Patient Survival: The overall mortality rate associated with elective primary THA is very low (<0.1-0.2%). The primary concern is quality of life and functional survival of the implant.
  • Quality of Life:
    • Pain Relief: Most patients experience significant (often complete) relief of hip pain. This is the primary driver of patient satisfaction.
    • Functional Improvement: Substantial improvement in walking ability, ability to perform ADLs, and participation in recreational activities. Most patients can return to low-impact sports (swimming, cycling, golf). High-impact activities (running, jumping sports) are generally discouraged.
    • Patient Satisfaction: Consistently high, with over 90-95% of patients reporting satisfaction with the outcome of their THA.
    • Psychological Well-being: Reduction in depression and anxiety related to chronic pain and disability.

Prevention

  • Primary (Preventing initial occurrence of severe hip disease requiring THA):
    • Weight Management: Crucial for reducing mechanical stress on the hip joint, slowing the progression of osteoarthritis.
    • Regular Exercise: Low-impact activities (swimming, cycling, walking) to maintain joint health, muscle strength, and flexibility. Avoid excessive high-impact activities if susceptible to joint degeneration.
    • Injury Prevention: Avoiding hip trauma (e.g., falls) to prevent post-traumatic arthritis.
    • Early Management of Inflammatory Conditions: Aggressive treatment of conditions like rheumatoid arthritis to prevent joint destruction.
    • Responsible Corticosteroid Use: Minimize prolonged, high-dose corticosteroid use when possible to reduce risk of avascular necrosis.
  • Secondary (Early detection and intervention to prevent progression or complications):
    • Early Diagnosis of Hip Conditions: Prompt evaluation and diagnosis of hip pain to initiate conservative management (PT, lifestyle modifications, pain management) before severe joint damage occurs.
    • Pre-operative Optimization: As described in Management, optimizing medical comorbidities (e.g., strict glycemic control in diabetics, smoking cessation, nutrition) to minimize surgical risks and improve outcomes.
    • Patient Education: Thoroughly educate patients on the risks and benefits of THA, realistic expectations, and post-operative precautions to prevent early complications like dislocation.
  • Tertiary (Preventing complications and maximizing function after THA):
    • Appropriate Surgical Technique: Meticulous surgical planning, precise component positioning, and appropriate implant selection by an experienced surgeon to minimize risks of dislocation, loosening, and LLD.
    • Strict Infection Control Protocols: Adherence to perioperative antibiotic prophylaxis, sterile technique, and appropriate wound care to prevent PJI.
    • Effective VTE Prophylaxis: Pharmacological and mechanical prophylaxis protocols tailored to patient risk factors to prevent DVT/PE.
    • Aggressive Post-operative Rehabilitation: Early mobilization and adherence to a structured physical therapy program to regain strength, range of motion, and prevent stiffness or disuse atrophy.
    • Adherence to Hip Precautions: If indicated by surgical approach (e.g., avoiding hip flexion >90 degrees, adduction past midline, internal rotation for posterior approach) to prevent dislocation.
    • Regular Follow-up: Periodic clinical and radiographic assessment to detect early signs of implant loosening, wear, or other complications, allowing for timely intervention.
    • Avoid High-Impact Activities: Patients are typically advised to avoid activities that place excessive stress on the artificial joint (e.g., running, jumping, contact sports) to prolong implant lifespan and prevent wear/loosening.

Special Populations

  • Pediatric:
    • Extremely rare. Indications typically include severe juvenile idiopathic arthritis, severe avascular necrosis (e.g., from sickle cell disease or steroid use), or severe developmental deformities.
    • Challenges: Skeletal immaturity, ongoing growth, higher activity levels leading to increased implant wear and revision rates, need for smaller and often custom implants.
    • Consideration for future revision surgeries due to longer life expectancy.
  • Geriatric:
    • The most common age group for THA.
    • Considerations: Increased prevalence of comorbidities (cardiac, pulmonary, renal), poorer bone quality (osteoporosis), higher risk of post-operative delirium, slower rehabilitation, increased fall risk.
    • Emphasis on comprehensive pre-operative medical optimization and multi-disciplinary care.
    • Cemented fixation often preferred due to osteoporosis.
    • Thorough fall prevention strategies pre- and post-operatively.
  • Pregnancy:
    • Elective THA is contraindicated during pregnancy.
    • If a hip condition arises during pregnancy, non-surgical management (pain control, physical therapy, activity modification) is the primary approach.
    • Surgery would be deferred until after delivery.
  • Comorbidities:
    • Obesity (BMI >30 kg/m², especially >40 kg/m²): Increased risk of PJI (up to 2-4x higher), DVT/PE, wound complications (hematoma, dehiscence), longer operative time, technical difficulties, and potentially higher revision rates. Pre-operative weight loss is strongly encouraged.
    • Diabetes Mellitus: Increased risk of PJI (especially with HbA1c >7.0%), delayed wound healing, DVT/PE. Strict perioperative glucose control (target blood glucose <180 mg/dL, ideally <140 mg/dL) is crucial.
    • Cardiovascular Disease: Increased risk of MI, stroke, and arrhythmias. Comprehensive pre-operative cardiac evaluation and optimization by a cardiologist. Often requires careful fluid management and anesthetic choices.
    • Renal/Hepatic Insufficiency: May affect drug metabolism (antibiotics, anticoagulants, analgesics), increase bleeding risk, and impact overall surgical tolerance. Dose adjustments may be necessary.
    • Immunosuppression: Patients on immunosuppressants (e.g., for RA, transplant recipients) have a higher risk of infection. May require temporary adjustment of immunosuppressive regimen in consultation with relevant specialists.
    • Smoking: Significant risk factor for wound complications, PJI, impaired bone healing, and pulmonary complications. Smoking cessation (at least 4-6 weeks prior) is highly recommended.

Clinical Pearls

  • Diagnostic:
    • Groin pain with limited internal rotation is the hallmark symptom of hip osteoarthritis. Always consider hip pathology for unexplained knee pain.
    • Standard X-rays (AP pelvis, frog-leg lateral) are usually sufficient for diagnosing advanced hip OA and are crucial for surgical planning. Do not routinely order MRI for typical OA.
    • Pre-operative ESR/CRP are essential in revision THA to screen for occult infection, even if no obvious signs of infection are present.
  • Treatment:
    • Multimodal pain management is key to reducing opioid requirements and improving early rehabilitation.
    • Early mobilization is paramount for preventing DVT/PE, improving range of motion, and accelerating recovery. Get the patient out of bed and walking on post-op day 0 or 1.
    • Strict adherence to VTE prophylaxis guidelines is non-negotiable to prevent life-threatening complications.
    • Surgical approach choice (posterior vs. anterior) often reflects surgeon preference and experience. While DAA may offer a faster initial recovery, long-term outcomes are comparable, and the choice does not definitively correlate with better outcomes across all surgeons.
    • Optimizing medical comorbidities pre-operatively (e.g., blood sugar, weight, smoking status) significantly impacts surgical success and complication rates.
  • Pitfalls:
    • Underestimating the complexity of patient comorbidities: Leading to perioperative complications.
    • Inadequate VTE prophylaxis: Resulting in DVT/PE.
    • Failure to treat pre-existing infections: Such as UTIs or dental abscesses, which can seed the joint and cause PJI.
    • Ignoring patient expectations: Leading to dissatisfaction even with a technically successful surgery.
    • Not emphasizing post-operative rehabilitation: Which can lead to prolonged recovery, stiffness, and suboptimal functional outcomes.
    • Dismissing new post-op pain: Always investigate new or worsening pain to rule out serious complications like infection or loosening, rather than simply attributing it to "normal recovery."

Recent Updates

  • Guidelines:
    • AAOS (American Academy of Orthopaedic Surgeons) Clinical Practice Guidelines: Regularly updated recommendations on appropriate indications, VTE prophylaxis, pain management, and preventing PJI. Current guidelines emphasize multimodal pain management, early mobilization, and de-escalation of post-operative antibiotics.
    • Enhanced Recovery After Surgery (ERAS) Protocols: Becoming standard of care for THA, focusing on pre-habilitation, optimized anesthesia, multimodal pain control, early mobilization, and reduced length of hospital stay.
  • Evidence:
    • Direct Anterior Approach (DAA): Growing evidence supports DAA for potentially faster initial recovery and lower early dislocation rates in experienced hands, though long-term functional outcomes and revision rates are generally comparable to other approaches. It may have a steeper learning curve.
    • Highly Cross-linked Polyethylene (XLPE): Long-term studies confirm superior wear properties and reduced osteolysis compared to conventional polyethylene, making it the standard bearing surface for most THAs.
    • Ceramic-on-Ceramic (CoC) and Ceramic-on-Polyethylene (CoP) Bearings: CoC offers extremely low wear rates and is favored in younger patients for potentially higher longevity, but carries a small risk of "squeaking." CoP combines the wear resistance of ceramic with the forgiving nature of polyethylene.
    • Tranexamic Acid (TXA): Strong evidence supports perioperative IV or topical TXA to significantly reduce blood loss and transfusion rates in THA, with no increased risk of VTE. Routinely used.
    • Opioid Sparing Strategies: Strong focus on reducing post-operative opioid use through regional anesthesia, multimodal analgesia, and patient education to mitigate the opioid crisis.
    • Outpatient THA: Increasing trend towards performing THA in an outpatient or same-day discharge setting for selected, healthy patients with good social support, facilitated by ERAS protocols.
  • Controversies:
    • Optimal Surgical Approach: Ongoing debate regarding the "best" approach (anterior vs. posterior vs. lateral). While DAA has gained popularity, each approach has its advantages, disadvantages, and learning curves. The most important factor remains surgeon experience and meticulous technique.
    • Duration of VTE Prophylaxis: While most guidelines recommend 10-14 days of pharmacological prophylaxis, some advocate for extended prophylaxis (up to 35 days) for specific high-risk patients. Balancing VTE risk vs. bleeding risk remains a challenge.
    • Routine Pre-operative Staphylococcus aureus Decolonization: While evidence suggests benefit, universal screening and decolonization protocols are not uniformly adopted across all institutions.
    • Role of Robotic-Assisted THA: While offering enhanced precision in component placement, clear evidence for superior long-term clinical outcomes or lower complication rates compared to conventional manual techniques is still emerging and subject to ongoing study. Cost-effectiveness is also a factor.

Key References

  • Guidelines:
    • American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for Total Hip Arthroplasty. Available at: www.aaos.org
    • ERAS® Society Guidelines for Perioperative Care in Total Hip and Knee Arthroplasty. Available at: www.erassociety.org
    • Infectious Diseases Society of America (IDSA) Guidelines for the Diagnosis and Management of Periprosthetic Joint Infection. Available at: www.idsociety.org
  • Studies:
    • Randomized Controlled Trials (RCTs) and Meta-analyses comparing surgical approaches (e.g., Anterior vs. Posterior THA outcomes, various journals like Journal of Bone and Joint Surgery (JBJS), Clinical Orthopaedics and Related Research (CORR), Journal of Arthroplasty).
    • Large Registry Studies: Data from national joint registries (e.g., National Joint Registry for England, Wales, Northern Ireland and the Isle of Man; Australian Orthopaedic Association National Joint Replacement Registry; Nordic Arthroplasty Register Association) provide robust long-term implant survival data and identify trends in implant usage and revision rates.
    • Studies on Highly Cross-linked Polyethylene: Landmark studies demonstrating reduced wear and osteolysis (e.g., long-term follow-up studies in JBJS, Journal of Arthroplasty).
    • Studies on Tranexamic Acid in Arthroplasty: Numerous RCTs and meta-analyses published in major surgical and orthopedic journals demonstrating its efficacy and safety.
  • Reviews:
    • Comprehensive review articles on current concepts in THA, PJI management, and pain management in journals like Orthopedic Clinics of North America, Seminars in Arthroplasty, and Current Reviews in Musculoskeletal Medicine.
    • UpToDate: Clinical topic reviews on Total Hip Arthroplasty.
    • Cochrane Database of Systematic Reviews: For evidence-based synthesis on specific interventions in hip replacement.

Dr. Vivek's AI | For Educational Purposes Only